← Eichor
Study identifier: NCT06932705 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Study to Compare to PK Characteristics and Safety Profiles Between PA-111 and PA-111A

Condition: Mixed Dyslipidemia  ·  Sponsor: Addpharma Inc.

PhasePhase 1
Planned participants48
Who can joinAll sexes, 19 Years to no upper limit
Healthy volunteersYes

About this study

Primary endpoint of this study is to evaluate the pharmacokinetic characteristics of PA-111 in healthy subjects.

This description comes directly from the study's public registry record.

Talk to the study team

JeongEun Park  ·  +82-31-891-6989  ·  parkje@addpharma.co.kr

Always discuss trial participation with your own doctor first.

Locations (1)

H Plus Yangji HospitalSeoul, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06932705